According to this study, the global Traditional Chinese Medicine for COVID-19 market size will reach US$ million by 2030.

Traditional Chinese medicine (TCM) for COVID-19 refers to herbal remedies and formulations used in traditional Chinese medicine to support recovery and manage symptoms associated with COVID-19.

The market for traditional Chinese medicine for COVID-19 is driven by the global health crisis and the search for effective treatments and supportive therapies. TCM has been integrated into the management of COVID-19 in some countries and has attracted interest as a potential complementary approach to conventional medical treatments. As the world continues to battle COVID-19, the demand for traditional Chinese medicine for COVID-19 management is expected to continue.

This report presents a comprehensive overview, market shares, and growth opportunities of Traditional Chinese Medicine for COVID-19 market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Lianhua Qingwen Capsule
• Jinhua Qinggan Granule
• Xuebijing Injection
• Other

Segmentation by Application:

• Adult
• Children

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Yiling Pharmaceutical
• Chase Sun Pharmaceutical
• Juxiechang Pharmaceutical